Part the Cloud Translational Gene Targeting Challenge
Alzheimer's Association
UM Funding ID
FD04027
Sponsor
Alzheimer's Association
Category
International
Description
This program focuses on increasing early phase human trials (Phase 1 and Phase 2) of potential therapies tailored to the genetic underpinnings of Alzheimer’s disease and related dementias internationally.
Each grant is limited to $1M USD (direct and indirect costs) for Phase 1 studies and $2M USD for Phase 2 studies over two or three years.
VPRI Contact
Michelina Violi
Research Grants Specialist (Health & International)Michelina [dot] .Violi [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 06-Aug-2025 5:00 pm EST |
Application | 04-Sep-2025 4:30 pm CST | 24-Sep-2025 5:00 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.